TrialAmerican journal of hematology2015

G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.

Pamela S Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.